mitomycin has been researched along with 4-hydroxycyclophosphamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Averette, HE; Donato, D; Nguyen, HN; Penalver, M; Perras, J; Sevin, BU | 1 |
Gebhart, E; Herrera, LA; Ostrosky-Wegman, P; Tittelbach, H | 1 |
Petru, E; Pöch, G; Vychodil-Kahr, S | 1 |
3 other study(ies) available for mitomycin and 4-hydroxycyclophosphamide
Article | Year |
---|---|
The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell lines.
Topics: Adenocarcinoma; Adenosine Triphosphate; Alkaloids; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Humans; Intercalating Agents; Kinetics; Luminescent Measurements; Melphalan; Mitomycin; Tumor Cells, Cultured; Uterine Neoplasms | 1992 |
Changes in the proliferation of human lymphocytes induced by several cytostatics and revealed by the premature chromosome condensation technique.
Topics: Cell Cycle; Cell Fusion; Cell Line; Cells, Cultured; Chromosomes; Cisplatin; Cyclophosphamide; Humans; Lymphocyte Activation; Lymphocytes; Melphalan; Mitomycin; Mitomycins; Phytohemagglutinins | 1991 |
Sigmoid model versus median-effect analysis for obtaining dose-response curves for in vitro chemosensitivity testing.
Topics: Antibiotics, Antineoplastic; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Mitomycin; Models, Statistical; Ovarian Neoplasms; Tumor Cells, Cultured | 1999 |